Database : HANSEN Search on : PIRAZINAS/USO TERAP [Subject descriptor] References found : 2 [refine] Displaying: 1 .. 2   in format [Detailed]

page 1 de 1

1 / 2

HANSEN

select to print

Id: 13292 Author: Opromolla, Diltor Vladimir Araujo Title: Results obtained with morphazinamide in the treatment of leprosy ..- Source: s.l; s.n; 1966. 15 p. ilus, tab, graf. Abstract: The results obtained with morphazinamide in a group of patients with lepromatous leprosy are presented. The drug was administered at the rate of 2gm daily for 6 months Clinically, the drug proved of value in treatment of leprosy. The results of bacilloscopic studies and histologic examinations were favorable, but insufficient to confirm the clinical impression The drug was perfectly tolerated It is recommended that other hospitals and institutions conduct trials with morphazinamide in order to rech final conclusions as to the drug´s antileprotic action, the appropriate dosage and duration of treatment, toleration, and the possibility of using morphazinamide in association with other suitable drugs.(AU). Descriptors: HANSENIASE/quimioter ANTITUBERCULOSOS/uso terap PIRAZINAS/uso terap Limits: HUMANO Electronic Medium: http://www.ilsl.br Location: BR191.1; 00595/s

2 / 2

HANSEN

select to print

Id: 13192 Author: Opromolla, Diltor Vladimir Araujo Title: Results obtained with morphazinamide in the treatment of leprosy ..- Source: s.l; s.n; 1966. 15 p. tab, graf, ilus. Abstract: The results obtained with morphazinamide in a group of patients with lepromatous leprosy are presented. The drug was administered at the rate of 2 gm daily for 6 months. Clinically, the group proved of value in the treatment of leprosy. The results of bacilloscopic studies and histologic examinations were favorable, but insufficient to confirm the clinical impression. The drug was perfectly tolerated. It is recommended that other hospitals and institutions conduct clinical trials with morphazinamide in order to reach final conclusions as to the drug's antileprotic action, the appropriate dosage and duration of treatment, toleration, and the possibility of using morphazinamide in association with other suitable drugs. (AU). Descriptors: HANSENIASE/quimioter PIRAZINAS/uso terap ANTITUBERCULOSOS/uso terap Limits: HUMANO Electronic Medium: http://www.ilsl.br Location: BR191.1; 00595/s

---

page 1 de 1

Refine the search

Database : HANSEN

Advanced form

Search for : Free form

		Search	in field
1			WordsTitle wordsAbstract wordsAuthorInstitutional authorSubject descriptorLimitsLanguageCountry, year publicationJournalType of literatureBibliographic levelMonography in seriesPublication typeConferenceUnique identifierLocationElectronic supportEntry dateRecord type
2	and or and not		WordsTitle wordsAbstract wordsAuthorInstitutional authorSubject descriptorLimitsLanguageCountry, year publicationJournalType of literatureBibliographic levelMonography in seriesPublication typeConferenceUnique identifierLocationElectronic supportEntry dateRecord type
3	and or and not		WordsTitle wordsAbstract wordsAuthorInstitutional authorSubject descriptorLimitsLanguageCountry, year publicationJournalType of literatureBibliographic levelMonography in seriesPublication typeConferenceUnique identifierLocationElectronic supportEntry dateRecord type

Search engine: iAH powered by WWWISIS

IAH - © BIREME/PAHO/WHO Latin American and Caribbean Center on Health Sciences Information